Elizabeth Warren and the FTC Are the Least of Amgen's Problems

The biotech company is facing a patent cliff scarier than Washington’s actions

Related Keywords

Washington ,United States ,Elizabeth Warren ,David Wainer ,Al Drago Bloomberg ,Dow Jones Company Inc ,Amgen ,All Rights ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Corporate Crime Legal Action ,Patents ,Financial Performance ,Earnings ,Corporate Industrial News ,Intellectual Property Rights ,Industrial Property Rights ,Political General News ,Crime Legal Action ,Content Types ,Factiva Filters ,C Ampe Executive News Filter ,C Ampe Industry News Filter ,Synd ,Wsj Pro Com ,Amgn ,Corporate Crime ,Legal Action ,Corporate ,Industrial News ,Political ,General News ,Crime ,Healthcare ,Life Sciences ,